Washington, DC - Building on President Obama’s announcement in his State of the Union Address, today the Administration is unveiling details about the Precision Medicine Initiative, a bold new research effort to revolutionize how we improve health and treat disease.  Launched with a $215 million investment in the President’s 2016 Budget, the Precision Medicine Initiative will pioneer a new model of patient-powered research that promises to accelerate biomedical discoveries and provide clinicians with new tools, knowledge, and therapies to select which treatments will work best for which patients.

Rancho Dominguez, California - At the request of the U.S. Food and Drug Administration, a federal judge from the U.S. District Court for the Central District of California today entered a consent decree of permanent injunction against Laclede, Inc. of Rancho Dominguez, California, and its president, Michael A. Pellico. Laclede is the manufacturer of Luvena Prebiotic products.

San Francisco, California - It’s an old maxim that to get a job done right you need the right tools, that’s why CIRM, California’s stem cell agency, today approved $29.75 million in funding for new approaches to overcome obstacles and advance stem cell research.

Washington, DC - The U.S. Food and Drug Administration announced today that it will strengthen its review of automated external defibrillators (AEDs) to help improve the quality and reliability of these devices.

Sacramento, California - California Department of Public Health (CDPH) director and state health officer Dr. Ron Chapman issued a Health Advisory and the “State Health Officer’s Report on E-Cigarettes: A Community Health Threat,” warning Californians of the toxicity of electronic cigarettes (e-cigarettes).

West Lafayette, Indiana - Low doses of metformin, a widely used diabetes medication, and a gene inhibitor known as BI2536 can successfully halt the growth of late-stage prostate cancer tumors, a Purdue University study finds.